Gordon, Jason Danne, Thomas Beresford-Hulme, Lee Bennet, Hayley Tank, Amarjeet Edmonds, Christopher Thorén, Fredrik Scheerer, Markus Florian McEwan, Phil Adverse Changes in HbA1c, Body Weight and Insulin Use in People With Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme <p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> Body weight;Dapagliflozin;HbA1c;Treatment discontinuation;Type 1 diabetes mellitus 2020-04-08
    https://adisjournals.figshare.com/articles/figure/Adverse_Changes_in_HbA1c_Body_Weight_and_Insulin_Use_in_People_With_Type_1_Diabetes_Mellitus_Following_Dapagliflozin_Discontinuation_in_the_DEPICT_Clinical_Trial_Programme/12005658
10.6084/m9.figshare.12005658.v1